Inventor · disambiguated record
Raeann Wu
Also filed as: WU RAEANN · WU RAEANN R · WU RAEANN RUIYUN
16 granted patents·5 pending applications·128 citations·filing 2006–2019
93Inventor score
Top patents by PatentIndex Score
21 records- 0194US8163904B2Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-BenzamideMANLEY PAUL W·Filed 2006·Granted Apr 24, 2012·32 cites·4 claims
- 0292US8389537B2Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideMANLEY PAUL W·Filed 2012·Granted Mar 5, 2013·17 cites·2 claims
- 0389US8415363B2Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideMANLEY PAUL W·Filed 2012·Granted Apr 9, 2013·15 cites·8 claims
- 0488US8580806B2Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideNOVARTIS AG·Filed 2013·Granted Nov 12, 2013·9 cites·2 claims
- 0588US8343984B2Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideNOVARTIS AG·Filed 2006·Granted Jan 1, 2013·11 cites·14 claims
- 0686US9796673B2L-tartrate salt of pridopidineWU RAEANN·Filed 2015·Granted Oct 24, 2017·10 cites·19 claims
- 0786US9163005B2Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideNOVARTIS AG·Filed 2013·Granted Oct 20, 2015·6 cites·1 claims
- 0886US8829015B2Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideNOVARTIS AG·Filed 2013·Granted Sep 9, 2014·7 cites·2 claims
- 0984US11390597B2Salt and solid state forms of escitalopramHASLETON MARK·Filed 2018·Granted Jul 19, 2022·2 cites·20 claims
- 1083US9067896B2Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl) -phenylamino]-pyrimidin-4-yl}-1-methyl-urea and salts thereofBERGHAUSEN JOERG·Filed 2010·Granted Jun 30, 2015·11 cites·15 claims
- 1179US10513526B2Solid state forms of spiro-oxindole compoundsXENON PHARMACEUTICALS INC·Filed 2018·Granted Dec 24, 2019·2 cites·11 claims
- 1278US10118932B2Solid state forms of spiro-oxindole compoundsXENON PHARMACEUTICALS INC·Filed 2017·Granted Nov 6, 2018·2 cites·11 claims
- 1369US9802931B2Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursorsNOVARTIS AG·Filed 2016·Granted Oct 31, 2017·1 cites·8 claims
- 1467US9365565B2Salts of aza-bicyclic di-aryl ethers and pharmaceuticals thereofMARTERER WOLFGANG·Filed 2012·Granted Jun 14, 2016·2 cites·16 claims
- 1567US8063043B2Salts of N-[6-cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4′-(trifluoromethoxy)[1,1′-biphenyl]-3-carboxamideBAJWA JOGINDER·Filed 2009·Granted Nov 22, 2011·1 cites·2 claims
- 1661US2014343087A1Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideMANLEY PAUL W·Filed 2014·Application pending·0 cites
- 1758US10421755B2Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursorsNOVARTIS AG·Filed 2017·Granted Sep 24, 2019·0 cites·13 claims
- 1857US2020109151A1Solid state forms of spiro-oxindole compoundsXENON PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1951US2012214810A1Salts of N-[6-cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamideBAJWA JOGINDER SINGH·Filed 2012·Application pending·0 cites
- 2048US2012035174A1Salts of N-[6-cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamideBAJWA JOGINDER SINGH·Filed 2011·Application pending·0 cites
- 2145US2009131528A1SaltFENG LILI·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →